These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence]. Chauchard E; Septfons A; Chabrol H Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064 [TBL] [Abstract][Full Text] [Related]
74. Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues. Bonaccorso S; Metastasio A; Ricciardi A; Stewart N; Jamal L; Rujully NU; Theleritis C; Ferracuti S; Ducci G; Schifano F Brain Sci; 2018 Jul; 8(7):. PubMed ID: 30011896 [TBL] [Abstract][Full Text] [Related]
75. Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: client and treatment characteristics and associations with first-time treatment seeking. Copeland J; Allsop D Drug Alcohol Rev; 2014 Sep; 33(5):565-71. PubMed ID: 24902861 [TBL] [Abstract][Full Text] [Related]
76. The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs. Banister SD; Kevin RC; Martin L; Adams A; Macdonald C; Manning JJ; Boyd R; Cunningham M; Stevens MY; McGregor IS; Glass M; Connor M; Gerona RR Drug Test Anal; 2019 Jul; 11(7):976-989. PubMed ID: 30838752 [TBL] [Abstract][Full Text] [Related]
77. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders. Thornton LK; Baker AL; Johnson MP; Lewin T Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458 [TBL] [Abstract][Full Text] [Related]
78. [Self-esteem, coping, perceived social support and substance use in young adults with a cannabis dependence disorder]. Dorard G; Bungener C; Corcos M; Berthoz S Encephale; 2014 Jun; 40(3):255-62. PubMed ID: 23928065 [TBL] [Abstract][Full Text] [Related]
79. Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. Winstock A; Lynskey M; Borschmann R; Waldron J J Psychopharmacol; 2015 Jun; 29(6):698-703. PubMed ID: 25759401 [TBL] [Abstract][Full Text] [Related]